Recent Comments

Comment RSS

Estradiol News and Research RSS Feed - Estradiol News and Research

Estradiol is a sex hormone. Mislabelled the "female" hormone, it is also present in males; it represents the major estrogen in humans. Estradiol has not only a critical impact on reproductive and sexual functioning, but also affects other organs including the bones.

Workshop on "Neuroeconomics and Endocrinological Economics" organized

20. November 2009 00:42
A workshop on "Neuroeconomics and Endocrinological Economics," to be held Nov. 20 and 21 at UC Davis, will be the first to bring together experts in neuroscience, economics and hormone physiology in one event, according to organizers. [More]

Posted in: Medical Science News

Tags: , , , , , ,

BioSante Pharmaceuticals applauds Boehringer Ingelheim for developing a therapy to treat HSDD

17. November 2009 03:13
BioSante Pharmaceuticals, Inc., a specialty pharmaceutical company developing products for female sexual health, including LibiGel® for the treatment of hypoactive sexual desire disorder (HSDD), applauds the efforts of Boehringer Ingelheim to develop a therapy to treat this unmet medical need. [More]

Study: Coffee might be effective to fight against colon cancer

13. November 2009 03:57
A compound in coffee has been found to be estrogenic in studies by Texas AgriLife Research scientists. [More]

Posted in: Medical Condition News

Tags: , , , , , , , ,

Graceway Pharmaceuticals acquires global rights to Gilead Sciences' GS 9191 anti-proliferative agent

7. November 2009 00:12
Graceway Pharmaceuticals, LLC, a portfolio company of GTCR Golder Rauner, LLC, today announced that the company has acquired from Gilead Sciences, Inc. the worldwide license, including related regulatory filings and intellectual properties, to Gilead’s investigational molecule, GS 9191, for topical use. GS 9191 is an anti-proliferative agent that works by inhibiting cellular DNA synthesis, leading to the induction of apoptosis, or programmed cell death. [More]

Posted in: Drug Trial News | Medical Condition News

Tags: , , , , , ,

Study: Estrogen replacement may help protect brain damage

4. November 2009 00:17
Eighteen years ago this month the National Institutes of Health (NIH) announced that it would sponsor a landmark study to examine women and cardiovascular disease. Known as the Women's Health Initiative (WHI), the study enrolled more than 161,000 women. [More]

Teva Pharmaceutical Industries net sales up 25%

3. November 2009 03:19
Teva Pharmaceutical Industries Ltd. today reported results for the quarter ended September 30, 2009. [More]

Posted in: Business / Finance

Tags: , , , , , , ,

National campaign to raise awareness of actinic keratosis

24. October 2009 03:50
Driver Aric Almirola is lending his voice to a national public education program to raise awareness of actinic keratosis (AK) -- a potential early warning sign of skin cancer -- as well as the long-term consequences of sun damage over a lifetime. The national campaign, "Is it AK or OK?" is sponsored by Graceway Pharmaceuticals, LLC, in partnership with The Skin Cancer Foundation. [More]

Posted in: Medical Condition News

Tags: , , , , , , , ,

Combination treatement for IVF patients may eliminate vaginal bleeding

23. October 2009 01:40
A prospective, multi-center study demonstrated that in IVF (in vitro fertilization) cycles supplemented with once-daily dosing of Crinone® vaginal progesterone gel and Estrace® oral estrogen, vaginal bleeding is rare in patients who become pregnant. Bleeding does occur in approximately one-quarter of patients who do not become pregnant. These data were presented at the American Society for Reproductive Medicine (ASRM) annual meeting in Atlanta. [More]

Schering-Plough announces 2009 third quarter financial results

22. October 2009 07:05
Schering-Plough Corporation (NYSE: SGP) today reported financial results for the 2009 third quarter. [More]

Bioidentical Hormones for breast cancer prevention

22. October 2009 00:19
For a sample of prevention awareness on Breast Cancer and overall health, there are key terms one is suggested to start on: BRCA; DHEA; Estradiol; Estriol; Free radicals; Insulin resistance; Melatonin; Premarin; Progesterone; SHBG; vitamin D. [More]

Positive data from BioSante Pharmaceuticals' LibiGel Phase III clinical development program

20. October 2009 08:06
BioSante Pharmaceuticals, Inc., today announced positive safety data in its ongoing LibiGel Phase III clinical development program. For the first time, unblinded data have been reviewed by the independent DMC of the LibiGel Cardiovascular and Breast Cancer Safety Study. Based on this review of unblinded data, the DMC unanimously recommended continuation of the study as described in the study protocol, with no modifications. [More]

Biosante Pharmaceuticals, Cell Genesys successfully complete merger

15. October 2009 00:43
BioSante Pharmaceuticals, Inc. and Cell Genesys, Inc., today announced the successful completion of their previously announced merger of Cell Genesys with and into BioSante, with BioSante as the surviving company, under which BioSante now has acquired all of the outstanding shares of Cell Genesys common stock. [More]

New soy germ-based ingredient improves menopausal symptoms

9. October 2009 05:50
SE5-OH containing Natural S-equol, a novel soy germ-based ingredient in a supplement, improved menopausal symptoms, including significantly reducing hot flash frequency by nearly 59 percent, according to a peer-reviewed study in Japanese women. [More]

HRT may increase urinary incontinence in postmenopausal women

7. October 2009 02:01
Grappling with the risks and benefits of hormone replacement therapy (HRT) is nothing new for postmenopausal women. Researchers have now added more fuel to the fire, with evidence that HRT could play a role in incontinence. [More]

Stockholders approve BioSante Pharmaceuticals–Cell Genesys merger

1. October 2009 00:48
BioSante Pharmaceuticals, Inc. and Cell Genesys, Inc., today announced that BioSante stockholders have approved the merger between the two companies with BioSante as the surviving company. [More]
News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.